Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. (PCSA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PCSA · as of Jun 9, 2026
Key Statistics
Explore Processa Pharmaceuticals, Inc. Data
pcsa stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 80.0%
The PCSA analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $225.00, representing +9197.52% upside from the current price of $2.42.
Competitors & Peers
pcsa competitorsPCSA
ALLR
ATHA
BCTX
CRIS
CTXRStock Performance
Full HistoryAbout Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development stage, committed to identifying and progressing therapeutic agents for patients with critical unmet medical re…
what is processa pharmaceuticals, inc. · pcsa stock overview · processa pharmaceuticals, inc. company profile · who is processa pharmaceuticals, inc. ceo · pcsa NASDAQ · processa pharmaceuticals, inc. headquarters · processa pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Processa Pharmaceuticals, Inc. (PCSA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 7, 2014. As of the latest trading session, PCSA stock price is $2.42, with a market capitalization of $5.5M. The stock has returned -70.20% over the past 12 months and -15.97% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Processa Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $225.00. In fiscal year 2025, Processa Pharmaceuticals, Inc. reported revenue of — and net income of -$13.6M. For detailed data — including Processa Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Processa Pharmaceuticals, Inc. (PCSA) stock price is $2.42. The stock is traded on NASDAQ under the ticker symbol PCSA. The 52-week range is $1.76 – $19.63.